Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Operating Expenses | 1,986 | 3,798 | 3,696 | 4,522 | 5,589 |
| Operating Income | -1,986 | -3,798 | -3,696 | -4,522 | -5,589 |
| Interest Expense | 631 | 619 | 605 | 610 | 541 |
| Other Income | 2 | 68 | 6 | 21 | 16 |
| Pre-tax Income | -2,614 | -4,348 | -4,295 | -5,111 | -6,115 |
| Net Income Continuous | -2,614 | -4,348 | -4,295 | -5,111 | -6,115 |
| Net Income | $-2,614 | $-4,348 | $-4,295 | $-5,111 | $-6,115 |
| EPS Basic Total Ops | -550.00 | -950.00 | -1,000.00 | -1,250.00 | -1,450.00 |
| EPS Basic Continuous Ops | -560.74 | -957.24 | -1,014.34 | -1,227.97 | -1,469.34 |
| EPS Diluted Total Ops | -550.00 | -950.00 | -1,000.00 | -1,250.00 | -1,450.00 |
| EPS Diluted Continuous Ops | -560.74 | -957.24 | -1,014.34 | -1,227.97 | -1,469.34 |
| EBITDA(a) | $-1,965 | $-3,779 | $-3,677 | $-4,509 | $-5,579 |